The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Insulizen
Insulin Resistance Reducer, Insulin Receptor Restore, and Blood Sugar Level Balance · LAGERSTROEMIA SPECIOSA LEAF 1 [hp_X]/1; MORINDA CITRIFOLIA FRUIT 1 [hp_X]/1 · Capsule · Oral · Hcbiopharm Llc
NDC 80353-0451-01 · 1 BOTTLE in 1 BOX / 1 CAPSULE in 1 BOTTLE / 60 CAPSULE in 1 CAPSULE · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Insulin Resistance Reducer, Insulin Receptor Restore, and Blood Sugar Level Balance (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Hcbiopharm Llc | LAGERSTROEMIA SPECIOSA LEAF 1 [hp_X]/1; MORINDA CITRIFOLIA FRUIT 1 [hp_X]/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Insulizen — NDC 80353-0451-01," retrieved September 3, 2026, https://drugdashboards.com/drug/80353045101.
Free to cite with attribution — see how the data is put together.